Interleukin-10 secretion by alveolar macrophages and monocytes in sarcoidosis

Respiration

Volumn 67, Issue 3, 2000, Pages 280-286

  Bingisser, Roland ^a,c   Speich, Rudolf ^a   Zollinger, Andreas ^b   Russi, Erich ^a   Frei, Karl ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Alveolar macrophages; Interleukin 10; Monocytes; Sarcoidosis; Transforming growth factor

Indexed keywords

INTERLEUKIN 10; LIPOPOLYSACCHARIDE; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; BRONCHOSCOPY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MALE; MONOCYTE; PRIORITY JOURNAL; SARCOIDOSIS;

EID: 0034033076     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029511     Document Type: Article

References (35)

1. Hunninghake GW, Crystal RG: Pulmonary sarcoidosis: A disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 1981;305:429-434.
2. Hol BE, Hintzen RQ, Van LR, Alberts C, Out TA, Jansen HM: Soluble and cellular markers of T cell activation in patients with pulmonary sarcoidosis. Am Rev Respir Dis 1993;148: 643-649.
3. Pforte A, Brunner A, Gais P: Concomitant modulation of serum-soluble interleukin-2 receptor and alveolar macrophage interleukin-2 receptor in sarcoidosis. Am Rev Respir Dis 1993;147:717-722.
4. Haslam PL, Parker D, Townsend PJ: Increases in HLA-DQ, DP, DR and transferrin receptors on alveolar macrophages in sarcoidosis and allergic alveolitis. Chest 1990;97:651-761.
5. Hunninghake GW: Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis. Am Rev Respir Dis 1984;129:569-372.
6. Pinkston P, Bitterman PB, Crystal RG: Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N Engl J Med 1983;308:793-800.
7. Steffen M, Petersen J, Oldigs M, Karmeier A, Magnussen H, Thiele H, Raedler A: Increased secretion of tumor necrosis factor-alpha, interleukin-1-beta, and interleukin-6 by alveolar macrophages from patients with sarcoidosis. J Allergy Clin Immunol 1993;91:939-949.
8. Car BD, Meloni F, Luisetti M, Semenzato G, Gialdroni GG, Walz A: Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med 1994;149:655-659.
9. Bachwich PR, Lynch J, Larrick J, Spengler M, Kunkel SL: Tumor necrosis factor production by human sarcoid alveolar macrophages. Am J Pathol 1986;125:421-425.
10. Prior C, Haslam P: Increased levels of serum interferon gamma in pulmonary sarcoidosis and relationship with response to corticosteroid therapy. Am Rev Resp Dis 1991;143:53-60.
11. Dauber JH, Wagner M, Brunsvold S, Paradis IL, Ernst I.A, Waggoner A: Flow cytometric analysis of lymphocyte phenotypes in bronchoalveolar lavage fluid - Comparison of a 2-color technique with a standard immunoperoxidase assay. Am J Respir Cell Mol Biol 1992;7: 531-541.
12. Frei K, Nadal D, Pfister HW, Fontana A: Listeria meningitis - Identification of a cerebrospinal fluid inhibitor of macrophage listericidal function as interleukin-10. J Exp Med 1993; 178:1255-1261.
13. 2) secreted by cells in culture. J Cell Physiol 1989;138:79-86.
14. Parker CW: Leukotrienes and prostaglandins in the immune system. Adv Prostaglandin Thromboxane Leukot Res 1986;133:855-860.
15. 2 production in resting macrophages. Biochem Biophys Res Commun 1986;136:94-101.
16. 2 release, alveolitis, and disease severity in sarcoidosis. Chest 1993;103:832-838.
17. Bachwich PR, Lynch J, Kunkel SL: Arachidonic acid metabolism is altered in sarcoid alveolar macrophages. Clin Immunol Immunopathol 1987;42:27-37.
18. Albina JE: On the expression of nitric oxide synthase by human macrophages. Why no NO? J Leukoc Biol 1995;58:643-649.
19. Bukrinsky MI, Nottet HS, Schmidtmayerova H, Dubrovsky L, Flanagan CR, Mullins ME, Lipton SA, Gendelman HE: Regulation of nitric oxide synthase activity in human immunodeficiency virus type I (HIV-1)-infected monocytes: Implications for HIV-associated neurological disease. J Exp Med 1995;181:735-745.
20. Kline JN, Schwartz DA, Monick MM, Floerchinger CS, Hunninghake GW: Relative release of interleukin-1-beta and interleukin-1 receptor antagonist by alveolar macrophages. A study in asbestos-induced lung disease, sarcoidosis, and idiopathic pulmonary fibrosis. Chest 1993;104:47-53.
21. Rolfe MW, Standiford TJ, Kunkel SL, Burdick MD, Gilbert AR, Strieter RM: Interleukin-1 receptor antagonist expression in sarcoidosis. Am Rev Respir Dis 1993;148:1378-1384.
22. Breen E, Shull S, Burne S, Absher M, Kelley J, Phan S, Cutroneo KR: Bleomycin regulation of transorming growth factor-beta mRNA in rat lung fibroblasts. Am J Respir Cell Mol Biol 1992;6:146-152.
23. Limper AH, Colby TV, Sanders MS, Asakura S, Roche PC, DeRemee RA: Immunohistochemical localization of transforming growth factor-beta-1 in the nonnecrotizing granulomas of pulmonary sarcoidosis. Am J Respir Crit Care Med 1994;149:197-204.
24. Zissel G, Homolka J, Schlaak J, Schlaak M, Muller-Quernheim J: Anti-inflammatory cytokine release by alveolar macrophages in pulmonary sarcoidosis. Am J Resp Crit Care Med 1996;154:713-719.
25. Bogdan C, Paik J, Vodovotz Y, Nathan C: Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-beta and interleukin-10. J Biol Chem 1992;267:23301-23308.
26. Jenkins JK, Malyak M, Arend WP: The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1-beta production in human monocytes and neutrophils. Lymphokine Cytokine Res 1994;13:47-54.
27. Dandrea A, Asteamezaga M, Valiante NM, Ma XJ, Kubin M, Trinchieri G: Interleukin-10 inhibits human lymphocyte interferon-gamma production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993;178:1041-1048.
28. Strickland DH, Thepen T, Kees UR, Kraal G, Holt PG: Regulation of T-cell function in lung tissue by pulmonary alveolar macrophages. Immunology 1993;80:266-276.
29. Herfarth HH, Mohanty SP, Rath HC, Tonkonogy S, Sartor RB: Interleukin-10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers. Gut 1996;39:836-845.
30. Baumer I, Zissel G, Schlaak M, Muller-Quernheim J: Th1/Th2 cell distribution in pulmonary sarcoidosis. Am J Respir Cell Mol Biol 1997;16:171-177.
31. Bai XF, Zhu J, Zhang GX, Kaponides G, Hojeberg B, van der Meide PH, Link H: IL-10 suppresses experimental autoimmune neuritis and down-regulates TH1-type immune responses. Clin Immunol Immunopathol 1997;83:117-126.
32. de Waal Malefyt R, Yssel H, de Vries JE: Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 1993;150:4754-4765.
33. Lester MR, Hofer MF, Gately M, Trumble A, Leung DY: Down-regulating effects of IL-4 and IL-10 on the IFN-gamma response in atopic dermatitis. J Immunol 1995;154:6174-6181.
34. Maeda H, Shiraishi A: TGF-beta contributes to the shift toward Th2-type responses through direct and IL-10-mediated pathways in tumor-bearing mice. J Immunol 1996;156:73-78.
35. Ramirez F, Fowell DJ, Puklavec M, Simmonds S, Mason D: Glucocorticoids promote a Th2 cytokine response by CD4+ T cells in vitro. J Immunol 1996;156:2406-2412.